As of 2026-09-25, the EV/EBITDA ratio of Cellectis SA (ALCLS.PA) is -3.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALCLS.PA's latest enterprise value is 209.29 mil EUR. ALCLS.PA's TTM EBITDA according to its financial statements is -61.88 mil EUR. Dividing these 2 quantities gives us the above ALCLS.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.8x - 7.0x | 6.4x |
| Forward P/E multiples | 5.8x - 7.1x | 6.4x |
| Fair Price | (2.91) - (3.41) | (3.16) |
| Upside | -339.4% - -380.5% | -360.5% |
| Date | EV/EBITDA |
| 2026-09-24 | -3.57 |
| 2026-09-23 | -3.58 |
| 2026-09-22 | -3.88 |
| 2026-09-21 | -3.75 |
| 2026-09-18 | -3.72 |
| 2026-09-17 | -3.54 |
| 2026-09-16 | -3.39 |
| 2026-09-15 | -3.80 |
| 2026-09-14 | -4.12 |
| 2026-09-11 | -6.42 |
| 2026-09-10 | -6.63 |
| 2026-09-09 | -6.63 |
| 2026-09-08 | -6.80 |
| 2026-09-07 | -6.98 |
| 2026-09-04 | -6.77 |
| 2026-09-03 | -7.06 |
| 2026-09-02 | -6.84 |
| 2026-09-01 | -6.86 |
| 2026-08-31 | -7.03 |
| 2026-08-28 | -7.25 |
| 2026-08-27 | -7.37 |
| 2026-08-26 | -7.23 |
| 2026-08-25 | -7.04 |
| 2026-08-24 | -6.67 |
| 2026-08-21 | -6.90 |
| 2026-08-20 | -7.08 |
| 2026-08-19 | -6.64 |
| 2026-08-18 | -6.45 |
| 2026-08-17 | -6.61 |
| 2026-08-14 | -6.59 |
| 2026-08-13 | -6.72 |
| 2026-08-12 | -6.47 |
| 2026-08-11 | -6.16 |
| 2026-08-10 | -6.10 |
| 2026-08-07 | -5.96 |
| 2026-08-06 | -5.99 |
| 2026-08-05 | -6.11 |
| 2026-08-04 | -6.01 |
| 2026-08-03 | -5.99 |
| 2026-07-31 | -6.08 |
| 2026-07-30 | -6.16 |
| 2026-07-29 | -6.19 |
| 2026-07-28 | -6.17 |
| 2026-07-27 | -6.25 |
| 2026-07-24 | -6.33 |
| 2026-07-23 | -6.07 |
| 2026-07-22 | -6.15 |
| 2026-07-21 | -6.00 |
| 2026-07-20 | -5.73 |
| 2026-07-17 | -5.76 |